Research Library
EARLY TRANSLATIONAL

Tesamorelin

Also known as: Tesamorelin, TH9507

Endocrine SignalingGrowth-Factor BiologyReceptor Pharmacology
ClassificationGrowth-hormone-releasing hormone (GHRH) analog peptide.
Catalog / SKUTesamorelin · MX-TESAMORE-010 · 10 mg
TargetsGHRH receptor

Molecular Overview

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone (GHRH) studied in endocrine research for its action on the GHRH receptor and the GH/IGF axis.

Mechanistic Background

GHRH-receptor agonism stimulates endogenous growth-hormone-releasing pathways studied in endocrine research.

What Researchers Study

Research has examined GHRH-receptor signalling and downstream GH/IGF-axis endpoints.

Evidence Landscape

Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Educational reference only; not a treatment recommendation.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.